1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
natrium
|
0.96 MG | Substance | HBESI |
|
magnesii stearas
|
- | Substance | HNIDK |
|
silica colloidalis hydrica
|
- | Substance | HNIDK |
|
gelatina
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 137.00
Specialties list
Yes
Generic
No
SL addition date:
15/03/1994
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 52068
- Drug name
- Mycobutin, Kapseln
- Galenic form
- KAHA
- ATC Code
- J04AB04
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 25/02/1994
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.02.1.
- Domain
- Human medicine
Package details
- Description (FR)
- MYCOBUTIN caps 150 mg 30 pce
- Description (DE)
- MYCOBUTIN Kaps 150 mg 30 Stk
- Market launch
- 25/02/1994
- Narcotic (BTM)
- No